Alnylam Pharmaceuticals

+$2.26 (+1.23%) As of 2:55 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO

John M. Maraganore

Employees

1,453

Headquarters

Cambridge, Massachusetts

Founded

2002

ALNY Key Statistics

Market Cap

22.07B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

493.40K

High Today

$186.99

Low Today

$184.45

Open Price

$184.54

Volume

263.38K

52 Week High

$209.73

52 Week Low

$119.29

ALNY News

Simply Wall StSep 20

Are Investors Undervaluing Alnylam Pharmaceuticals, Inc. By 49%?

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Alnylam Pharmaceuticals, Inc. ( ) as an investment opportunity

Analyst Ratings

48%

of 23 ratings

Buy

47.8%

Hold

47.8%

Sell

4.3%

ALNY Earnings

-$2.23

-$1.49

-$0.74

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 4, Pre-Market